BMS CEO optimistic re future of medical research
Giovanni Caforio, chairman and CEO of Bristol Myers Squibb, was recently interviewed in Fortune: “If there is any good news coming out of the coronavirus pandemic, it’s...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
Giovanni Caforio, chairman and CEO of Bristol Myers Squibb, was recently interviewed in Fortune: “If there is any good news coming out of the coronavirus pandemic, it’s...
Biohaven reports the appointment of pharmaceutical industry leader Robert J. Hugin to its board of directors, effective immediately. Hugin previously was chairman and chief executive officer...
P2 Science has closed on a $3 million line of credit with Webster Bank. The company, which has a manufacturing plant in Naugatuck and research...
Last week at BIO Digital, Dr. Michelle McMurry-Heath, BIO’s President & CEO, moderated the panel “Leading Through Crisis: Speaking Up and Out on Equity, Diversity,...
Azitra has opened its new 12,000 square foot laboratory and office complex in Branford, CT. Previously operating out of three small labs located at the...
The Connecticut Legislature’s Regulations Review Committee has approved two new conditions to allow patients with chronic pain and an inherited disorder that affects the body’s...
Having a faulty gene linked to dementia doubles the risk of developing severe COVID-19, according to a large-scale study. Researchers at the University of Exeter...
A type of personalized care known as precision medicine, and its subset, genomic medicine, is now the standard of care in Connecticut’s Hartford HealthCare Cancer Institute, UConn...
“Black Lives Matter and BioCT is committed to addressing racism through members’ employment practices, their development of therapeutics to benefit all patients and our support of...
Pfizer is establishing the Pfizer Breakthrough Growth Initiative, through which Pfizer will invest up to $500 million in biotechnology companies to help provide funding and...